These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 190610)

  • 21. CI-719 in hyperlipoproteinaemia: interim data.
    Bremner WF; Third JL; Clark B; Corstorphine C; Lawrie TD
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):83-7. PubMed ID: 798201
    [No Abstract]   [Full Text] [Related]  

  • 22. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of the plasma lipoproteins.
    Lewis B
    Sci Basis Med Annu Rev; 1972; ():118-44. PubMed ID: 4344060
    [No Abstract]   [Full Text] [Related]  

  • 24. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
    Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemfibrozil--a new lipid lowering agent.
    Nash DT
    J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
    Honorato J; Masso RM; Purroy A
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):78-9. PubMed ID: 798200
    [No Abstract]   [Full Text] [Related]  

  • 27. Gemfibrozil in a group of diabetics.
    de Salcedo I; Gorringe AL; Silva JL; Santos JA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):64-70. PubMed ID: 1019155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of fibrates on VLDL and LDL lipoprotein composition and parameters of their oxidation in hypertriglyceridemia].
    Zeman M; Zák A; Tvrzická E; Konárková M; Stípek S
    Cas Lek Cesk; 2002 Apr; 141(7):211-6. PubMed ID: 12053756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary regulation of plasma lipoprotein metabolism in humans.
    Havel RJ
    Prog Biochem Pharmacol; 1983; 19():110-22. PubMed ID: 6338520
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of gemfibrozil on serum lipids in diabetic patients.
    Konttinen A; Kuisma I; Ralli R; Pohjola S; Ojala K
    Ann Clin Res; 1979 Dec; 11(6):240-5. PubMed ID: 398183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolism of serum lipoprotein--with special reference to metabolism of endogenous triglycerides].
    Uzawa H
    Saishin Igaku; 1972 Mar; 27(3):476-81. PubMed ID: 4336582
    [No Abstract]   [Full Text] [Related]  

  • 34. [Transport in blood and mode of action of a hypolipodemic agent related to clofibrate: G P 45.699. Presence in low density serum lipoproteins].
    Beaumont JL; Dachet C; Beaumont V; Buxtorf JC
    Nutr Metab; 1971; 13(6):349-63. PubMed ID: 4337174
    [No Abstract]   [Full Text] [Related]  

  • 35. Summary of present data from a clinical trial of CI-719.
    Wilkening J; Schwandt P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):90-3. PubMed ID: 1019158
    [No Abstract]   [Full Text] [Related]  

  • 36. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
    Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability.
    O'Neal DN; O'Brien RC; Timmins KL; Grieve GD; Lau KP; Nicholson GC; Kotowicz MA; Best JD
    Diabet Med; 1998 Oct; 15(10):870-7. PubMed ID: 9796889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of tetracycline on the hepatic secretion of triglyceride.
    Breen K; Schenker S; Heimberg M
    Biochim Biophys Acta; 1972 May; 270(1):74-80. PubMed ID: 4338742
    [No Abstract]   [Full Text] [Related]  

  • 39. New lipid-lowering drug now on the market.
    JAMA; 1982 Mar; 247(11):1540. PubMed ID: 6950126
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lipoproteins as functional associates of protein-lipid complexes (literature review)].
    Titov VN
    Klin Lab Diagn; 1997 Jul; (7):13-9. PubMed ID: 9340085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.